There's a lot of buzz about the gut microbiome—the trillions of microbes that help us digest food and support the immune system. But your mouth is also home to its own highly specialized microbial community, and new research suggests that these oral microbes may play an equally important role in maintaining health.

Why can a chemical eye injury continue to worsen long after the initial burn, leading to corneal opacity, abnormal blood vessel growth, and even vision loss? The danger of corneal alkali burns lies not only in the rapid tissue penetration of alkaline agents, but also in their ability to disrupt the cellular cooperation required for corneal repair. A new study published in Eye Discovery by researchers from the Eye Institute of Shandong First Medical University and collaborating institutions uses single-cell RNA sequencing to map how corneal and limbal tissues respond to alkali injury, revealing a multicellular disease process centered on amplified VEGF signaling.

Cambridge, Mass. — June 3, 2026 — Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, appoints Jue Wang, PhD as Global Head of Business Development. The appointment is expected to further accelerate the commercialization of Insilico’s proprietary Pharma.AI platform and generative AI foundation ecosystem centered around MMAI Gym, as well as global out-licensing and R&D collaboration of Insilico's diverse portfolio of AI-driven therapeutic assets.

Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise cancer drugs. The finding also reveals important limitations in today’s artificial intelligence tools for drug discovery. The study, published in the June 2 online issue of the Journal of the American Chemical Society [10.1021/jacs.6c05178], focused on PKMYT1, a type of protein known as a kinase that helps control how cells grow and divide. Because this process can go wrong in cancer, PKMYT1 has emerged as a promising target for new cancer drugs.